ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,308, issued on July 8, was assigned to TPCERA LTD. (Jerusalem).
"Phosphorylcholine conjugates and uses thereof" was invented by Yehuda Shoenfeld (Ramat Gan, Israel) and Miriam Blank (Tel Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides phosphorylcholine conjugates and pharmaceutical compositions comprising same for the prevention or treatment of autoimmune diseases. In particular, the conjugates of the present invention are effective in treating autoimmune diseases associated with pathological inflammation."
The patent was filed on May 8, 2023, under Application No. 18/144,387.
*For further information, inc...